JP Patent
JP4937258B2 — 投与量制限機構及び付加的安全機構を備えた注射装置
Assigned to ノボ・ノルデイスク・エー/エス · Expires 2012-05-23 · 14y expired
What this patent protects
Patent listed against Ozempic.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.